Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Medpace Holdings Inc (MEDP) vs Trade Desk Inc (TTD) Price & Performance

Medpace Holdings IncTrade
Trade Desk IncTrade

Price performance (Past 24H)

Key statistics

Medpace Holdings Inc vs Trade Desk Inc — how do they compare? Medpace Holdings Inc trades at $600.79 (market cap $16.90B), while Trade Desk Inc trades at $13.39 (market cap $6.37B). The key difference: Medpace Holdings Inc is far larger — about 2.7× Trade Desk Inc's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, Trade Desk Inc nearer its low. Which is the better fit depends on your goals.

MEDPTTD
Market Cap
$16.90B$6.37B
Sector
TechnologyTechnology
52-Week High
$620.59$55.36
52-Week Low
$393.42$13.39
Enterprise Value
$16.52B$5.32B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Medpace Holdings Inc

MEDP trades at $600.00, down 0.4% on the day, with a bullish technical signal driven by moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $4.25, and raised full-year guidance. Revenue growth is robust, with 2026 projected at $2.8 billion, though valuation multiples like a P/E of 35.58 and P/B of 38.95 are elevated. Net cash flow is expected to turn positive in 2026, and institutional activity is mixed, with some funds increasing stakes while others trim positions.

Outlook is positive due to earnings momentum and record bookings, but risks include high valuation sensitivity and a shareholder lawsuit investigation. Analyst consensus is a $599.57 price target with a 'Hold' bias, suggesting limited near-term upside from current levels amid growth-priced expectations.

Trade Desk Inc

The Trade Desk (TTD) stock trades at $13.33, near its 52-week low, reflecting a bearish technical trend with recent earnings misses and a 12% revenue decline guidance for Q3 2026. Despite strong profitability margins, the company faces execution gaps and competitive pressures in the ad-tech sector, leading to significant analyst downgrades and negative media sentiment.

Outlook remains cautious with high risk; potential exists if operational improvements reverse recent declines, but near-term headwinds from weak guidance and macroeconomic pressures suggest continued volatility. The stock's valuation appears reasonable, but investor confidence hinges on a demonstrated turnaround in revenue growth and execution stability.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Read more on MEDP

About Trade Desk Inc

The Trade Desk Inc is engaged in providing a technology platform for ad buyers. Through its cloud-based platform ad buyers can create, manage, and optimize data-driven digital advertising campaigns across ad formats and channels, including display, video, audio, in-app, native and social, on a multitude of devices. Its products include Data Management Platform, Cross-Device Targeting, Video Advertising, Mobile Advertising, and others.

Read more on TTD